Insider · CIK 0002122703
Daniel B. Gilmer
Files at ARMP (Armata Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Daniel B. Gilmer files SEC Form 4 as director at ARMP (Armata Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Daniel B. Gilmer has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +51,280 | $0.00 | $0 | 51,280 | Apr 28, 2026 |
Questions about Daniel B. Gilmer
Answered from the filings on this page, as of the latest one.
Is Daniel B. Gilmer buying or selling?
Daniel B. Gilmer has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Daniel B. Gilmer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Daniel B. Gilmer has 0.
Where does Daniel B. Gilmer file Form 4?
Daniel B. Gilmer has filed Form 4 at ARMP (Armata Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.